Senior Financial Analyst
Danaher Corporation
Summary
The Senior Financial Analyst, General & Administration, is a key member of the Corporate Finance team, reporting to Corporate FP&A Director. This position will act as direct business partner with business leaders and is responsible for development of accurate headcount, expense and capital budgets/forecasts, timely corporate submissions, month-end FP&A close activities, and management reporting.
Job description
In this role, you will have the opportunity to:
- Act as business partner for G&A Leaders – while establishing a regular cadence with business partners to review monthly actuals, analyze forecast variance, identify trends and provide recommendations to drive forecast execution and accuracy. Prepare and distribute monthly/quarterly management review packages.
- Evaluate results to plan, drive variance analysis and provide partnership to business leaders to execute on plan; analyze historical, current, and projected financial data for use in planning, forecasting, and management decision making.
- Perform in-depth financial & operational analysis and quarterly/annual forecast modeling, including operating expenses, headcount and capital, to accelerate future business planning decisions.
- Actively participate in cross-functional projects designed to solve business problems and improve profitability.
- Conduct ad-hoc planning and analysis to support the business and senior management.
Requirements
- Bachelor's degree in finance, accounting, economics or related field
- 4+ years of relevant financial planning and analysis experience
- Understanding of accounting processes, procedures and internal controls
- Advanced user in MS Excel
- ERP/planning applications experience (SAP/OneStream preferred)
Benefits
- Paid Time Off
- Medical Insurance
- Dental Insurance
- Vision Insurance
- 401(k)
- Bonus/Incentive Pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.